Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...

For reference, Novo Nordisk also offers a highly successful weight loss drug, Wegovy, a GLP-1 receptor agonist.

Eli Lilly said on Thursday that India's drug regulator had approved the launch of pre-filled injector pens of its blockbuster ...

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

As the markets for weight-loss drugs develop, pharma companies are having to adapt in search of the next big thing.

Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

A Chinese-developed GLP-1 drug is as effective as Ozempic or Zepbound, clinical trial says ...